丙酮酸对大鼠局灶性脑缺血后梗死体积和神经功能缺损的影响
Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats
摘要:
最近的实验证据表明,糖酵解的最终代谢产物丙酮酸对不同类型的脑损伤具有显著的保护作用。本研究的目的是评估丙酮酸盐给药后在大鼠永久性大脑中动脉闭塞(pMCAO)诱导的缺血性卒中模型中的神经保护作用和神经功能结局。三个剂量的丙酮酸盐(250、500和1000 mg/kg,i. p.)或载体在pMCAO后30分钟腹膜内施用。在另一组实验中,在缺血之前、缺血之后立即或在长期给药模式中给予丙酮酸盐。卒中后24小时测定功能结局、死亡率和梗死体积。即使最低剂量的丙酮酸盐降低了死亡率和神经功能缺损,也没有观察到梗死体积的伴随减少。pMCAO后30分钟给予最高剂量的丙酮酸盐可使皮质梗死增加27%。此外,当在pMCAO之前给予丙酮酸盐时,注意到神经功能缺损显著增加。令人惊讶的是,在短暂性全脑缺血的情况下发现的相反,目前的研究结果不支持丙酮酸在永久性局灶性脑缺血中具有很大的神经保护作用,表明这种糖酵解代谢产物在缺血性脑中的作用涉及两种不同的机制。
英文摘要:
Recent experimental evidences indicate that pyruvate, the final metabolite of glycolysis, has a remarkable protective effect against different types of brain injury. The purpose of this study was to assess the neuroprotective effect and the neurological outcome after pyruvate administration in a model of ischemic stroke induced by permanent middle cerebral artery occlusion (pMCAO) in rats. Three doses of pyruvate (250, 500 and 1000 mg/kg, i.p.) or vehicle were administered intraperitoneally 30 min after pMCAO. In other set of experiments, pyruvate was given either before, immediately after ischemia or in a long-term administration paradigm. Functional outcome, mortality and infarct volume were determined 24 h after stroke. Even when the lowest doses of pyruvate reduced mortality and neurological deficits, no concomitant reduction in infarct volume was observed. The highest dose of pyruvate increased cortical infarction by 27% when administered 30 min after pMCAO. In addition, when pyruvate was given before pMCAO, a significant increase in neurological deficits was noticed. Surprisingly, on the contrary of what was found in the case of transient global ischemia, present findings do not support a great neuroprotective role for pyruvate in permanent focal cerebral ischemia, suggesting two distinct mechanisms involved in the effects of this glycolytic metabolite in the ischemic brain.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。